Back to search

Article

Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre

2022-02-11

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Glycogen storage disease type Ib (GSD Ib) is a severe disorder of carbohydrate metabolism due to bi-allelic variants in <italic>SLC37A4</italic>. It is associated with neutropaenia and neutrophil dysfunction, which has recently been attributed to the accumulation of 1,5-anhydroglucitol-6-phosphate (1,5AG6P) within neutrophils. Treatment with sodium-glucose co-tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d94be54-0b07-522a-a7ce-49ec2ea2eb22
DOI
10.21203/rs.3.rs-1260734/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centreDOI 10.21203/rs.3.rs-1260734/v1
Select a neighboring publication to make it the new centre.